Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

80%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Not yet recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (20.0%)

N/A4 (80.0%)

Trials by Status

completed360%

not_yet_recruiting120%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes

NCT02040571

completednot_applicable

Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus

NCT01418703

Clinical Trials (5)

Showing 5 of 5 trials

NCT06959797Not Applicable

Insulin Pump Versus Full Closed-loop for Type 2 Diabetes

Not Yet Recruiting

NCT01534013Not Applicable

Clinical Assessment of a Closed-loop Insulin Delivery System

Completed

NCT01882075Phase 4

Closed-loop Fluid Administration System: Pilot Study to Evaluate Feasibility

Terminated

NCT02040571Not Applicable

The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes

Completed

NCT01418703Not Applicable

Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5